DUBLIN, Febụwarị 24, 2022 – (WIRE azụmaahịa) – agbakwunyere akụkọ “China in Vitro Diagnostics Market, Size, amụma 2022-2027, Trends Industry, Uto, Share, Mmetụta nke COVID-19, Nyocha ụlọ ọrụ” na ResearchAndMarkets. com na-enye.
The Chinese In-vitro diagnostics (IVD) Market bụ isi na inye nlekọta ahụike n'ụwa nile, na a na-eme atụmatụ na $ 18.9 ijeri na 2027. E wezụga nke ahụ, China bụ nnukwu ụlọ nyocha ụlọ ọgwụ na Asia na otu n'ime ụwa na-eto ngwa ngwa. ngalaba ahụike.
N'ụzọ dị ịrịba ama, n'ime afọ ndị gara aga, ọnụ ọgụgụ nke akụ na ụba China dị egwu, na-ebute ọganihu na-enye ego na GDP kwa afọ.Na mgbakwunye, odida obodo China IVD ejirila akụkọ ihe mere eme na-achịkwa nnukwu ndị na-eweta mba ụwa, yana ndị na-eweta ngwa ụlọ na ole na ole.Ọzọkwa, na-achọ mgbanwe, ụlọ ọrụ mmalite ahụ na-ahụ mgbanwe nke nyiwe nchọpụta nchọpụta na nyocha na-egosi ngwa ngwa maka ọtụtụ ihe nrịbama na-adabere na ọbara.
Ụlọ ọrụ China In-Vitro Diagnostics Industry na-amụba site na iji ọnụọgụ abụọ CAGR nke 16.9% n'oge 2021-2027
Ụlọ ọrụ IVD nke China na-eto eto ruo ọtụtụ afọ ma nwee nnukwu nyocha na mmepụta ihe zuru ụwa ọnụ.Na China, a na-achọ ụlọ ọgwụ siri ike maka mmepe nke ụlọ ọrụ IVD na-aga n'ihu.Agbanyeghị, ihe nyocha ọhụụ na-apụta mgbe niile, na-achọ ụlọ nyocha ụlọ ọgwụ iji rụọ ọrụ nnwale ọzọ yana ụlọ ọrụ IVD iji chepụta teknụzụ na ngwaahịa ọhụrụ.Ọzọkwa, na ọnọdụ obibi ndụ ka mma nke ndị China na ngwa ngwa ịka nká nke ndị China, ọchịchọ maka nlekọta ahụike ezinụlọ na-abawanye;ụzọ a ga-esi bụrụ ebe dị mkpa maka ụlọ ọrụ nyocha in vitro.
Kedu ka Coronavirus si baara China In-Vitro Diagnostics Market Uto Uto
COVID-19 akwalitela uto nke ụlọ ọrụ nyocha In-vitro na China.Dịka China jigidere amụma COVID efu, yabụ iji nweta ọnụ ọgụgụ buru ibu nke nnwale PCR na nyocha ngwa ngwa Antigen kwesịrị ime.N'ihi ụdị COVID dị ka Alfa, Beta, Gamma Delta, Delta Plus na Omnicorn n'oge na-adịbeghị anya, ule PCR na ule Antigen ngwa ngwa ga-aga n'ihu na-eme n'ọtụtụ buru ibu.Dabere na onye bipụtara ya, China In-Vitro Diagnostics Market Size bụ ijeri US $ 7.4 na 2021.
Akụkụ Nchọpụta Molecular na-edeba aha uto siri ike
Na akụkọ ahụ, ekewaala ahịa ahụ n'ime kemịkalụ ụlọ ọgwụ, Immunoassay, Molecular Diagnostic, Microbiology, Hematology, and Self-Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT), na Coagulation.Na IVD, otu n'ime ọganihu ndị kasị baa uru bụ n'ụdị ngwá ọrụ nchọpụta molecular.Dị ka nyocha ahụ si kwuo, mmeghachi omume nrịanrịa polymerase bụ ihe mbụ a na-ahụkarị na nchọpụta mkpụrụ ndụ.
Na mgbakwunye, ngwaahịa PCR nke adịla n'otu oge na-achọpụta nje, nje bacteria, fungi, na nje nje, na-ekwe ka ụlọ nyocha molekụla belata ọnụ ahịa ma na-ebute nsonaazụ ka mma na nyocha mkpụrụ ndụ.N'ụzọ dị ịrịba ama, a na-eji ule nyocha mkpụrụ ndụ achọpụta usoro kpọmkwem na DNA ma ọ bụ RNA (gụnyere otu nucleotide polymorphism (SNP), nhichapụ, nhazigharị, ntinye, na ndị ọzọ) nke nwere ike ma ọ bụ enweghị ike jikọta ya na ọrịa ọ bụla.
Ndị na-egwu egwu na China IVD Market
Nnukwu ụlọ ọrụ IVD mba ụwa enweelarị nnukwu ọnụnọ n'ahịa China ma na-anọchite anya ihe mgbochi nwere ike ịsọ mpi maka ndị na-abata ahịa.Ndị isi egwuregwu gụnyere Roche Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories, Danaher Corporation, na bioMerieux SA.
Companieslọ ọrụ ndị a na-enweta nnukwu ego ego iji nweta ụgwọ ọrụ metụtara asambodo ngwaahịa, nnwale ụlọ ọgwụ, na nnọchite anya ndị nnọchi anya.Na mgbakwunye, ụlọ ọrụ ndị a nwere ike ịme ihe ndị dị mkpa iji guzobe nkesa ozugbo yana ọrụ nrụpụta mpaghara.
Akụkụ ekpuchiri
Clinical Chemistry Market
Immunoassay Market
Azụmahịa Nchọpụta Molecular
Ahịa Microbiology
Ahịa Hematology
Nyochaa onwe nke ahịa Glucose ọbara (SMBG).
Ọnụ ahịa Nleba Nleba anya (POCT).
Ahịa Coagulation
Oge nzipu: Mar-11-2022